(Q39929092)

English

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study).

scientific article published on 18 April 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study). (English)
Jean-François Morère
Jeanne-Marie Bréchot
Virginie Westeel
Valerie Gounant
Fabrice Barlési
Pierre-Jean Souquet
Didier Debieuvre
Laurence Baudrin
Gérard Zalcman
Bernard Milleron
Denis Moro-Sibilot

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit